BiondVax Pharmaceuticals Ltd. (BVXV) Social Stream
BIONDVAX PHARMACEUTICALS LTD (BVXV) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering BVXV.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Current Price||Upside Potential|
Price Target Last Issued December 8, 2022
BVXV reports an average of 1,961.46% for its upside potential over the past 43 weeks.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Share Price||Upside Potential|
BVXV Broker Recommendations Summary
|Average Broker Rating||Strong Buy||Buy||Hold||Sell||Strong Sell||Analysts Issuing Recs|
The Trend in the Broker Recommendations
Over the past 91 days, BVXV's average broker recommendation rating improved by 0.
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for BVXV as an investment opportunity.
- BIONDVAX PHARMACEUTICALS LTD's number of analysts covering the stock is greater than nearly none of all US stocks.
- BIONDVAX PHARMACEUTICALS LTD's upside potential (average analyst target price relative to current price) is higher than 370.99% of all US stocks.
- To contextualize these metrics, consider that out of stocks in the small market cap category, BIONDVAX PHARMACEUTICALS LTD's average analyst price target is greater than 229.15% of them.
- BVXV has a lower variance in analysts' estimates than 12.37% of Pharmaceutical Products stocks.
In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to BIONDVAX PHARMACEUTICALS LTD are DBVT, EIGR, and OCGN.
Is BVXV a Buy, Hold or Sell? See the POWR Ratings now!